Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Int J Cancer. 2011 May 15;128(10):2373–2381. doi: 10.1002/ijc.25570

Table 5.

PSA dynamics significantly associated with prostate-cancer–specific mortality with adjustment for PSA: comparison of results against previously published analyses with an MSKCC cohort.8

TAPG cohort: disease-specific mortality for
untreated patients		 MSKCC cohort: metastases after radical
prostatectomy
Number (%)
with
calculable
dynamic		 Number of
events		 Enhancement
PSA + PSA
dynamics vs PSA		 Number (%)
with
calculable
dynamic		 Number of
events		 Enhancement
PSA + PSA
dynamics vs PSA
Velocity
D’Amico A4 492 (83) 106 −0.051 2630 (90) 56 None
D’Amico A >2
ng/mL/yr4 		492 (83) 106 0.008 2630 (90) 56 None
D’Amico B5 90 (15) 15 −0.027 876 (30) 16 0.030
D’Amico B >2
ng/mL/yr5 		90 (15) 15 0.003 876 (30) 16 None